Hospital Clínic of Barcelona
Barcelona, 08028, Spain
NCT Number: NCT01201720
The purpose of this study is to evaluate the effects on plasma exchange with 5% albumin on albumin functional capacity, cardiocirculatory, renal and cerebral function in cirrhotic patients with "acute-on-chronic liver failure".
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Barcelona, 08028, Spain
The purpose of this study is to evaluate the effects on plasma exchange with 5% albumin on albumin functional capacity, cardiocirculatory, renal and cerebral function in cirrhotic patients with "acute-on-chronic liver failure", renal disfunction, cerebral disfunction ,and inflamtory response
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Realization of 6 plasma exchange with albumin in 11 days
Other names: Albumina grifols 5%
Time frame: 10 days
Albumin binding capacity
Time frame: 10 days
Electron Paramagnetic Resonance Spectroscopy
Time frame: 10 days
Ischemia-modified albumin
Time frame: 10 days
Plasma renin activity
Time frame: 10 days
Plasma concentration of noradrenaline
Time frame: 11 days
Systemic hemodynamic study and portal venous pressure
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Conventional hepatic function parameters: aspartate transaminase, alanine transaminase, gamma-glutamyl transferase, alkaline phosphatase, total, conjugated and not conjugated serum bilirubin, serum albumin, international normalized ratio (INR) and prothrombin index
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 1 month
Time frame: 10 days
Hepatic toxin concentration: biliary acids, aromatic amino acids, ammonium and lactatum.
Instituto Grifols, S.A.
Industry
Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Liver Failure"
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00287235
Brain Diseases, Brain Diseases, Metabolic
Birmingham, Alabama, United States
View Trial DetailsNCT04789213
Behavior, Digestive System Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03723317
Digestive System Diseases, Fibrosis
Brussels, Belgium
View Trial DetailsNCT07053488
Digestive System Diseases, Digestive System Neoplasms
Beijing, Changping, China
View Trial Details